About Bioline  All Journals  Testimonials  Membership  News

Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
ISSN: 1596-5996
EISSN: 1596-5996
Vol. 14, No. 9, 2015, pp. 1573-1579
Bioline Code: pr15205
Full paper language: English
Document type: Research Article
Document available free of charge

Tropical Journal of Pharmaceutical Research, Vol. 14, No. 9, 2015, pp. 1573-1579

 en Inhibition of SENP5 by Cucurbitacin B Suppresses Cell Growth and Promotes Apoptosis in Osteosarcoma Cells
Zhong, Jiang-Bo; Liu, Zhao-Rui; Liu, Sen & Zhao, Jian-Qiang


Purpose: To investigate the effect of cucurbitacin B on the expression of SUMO-specific proteases (SENP5).
Methods: Effect of cucurbitacin B (10-50 mg/mL) on viability of U2OS and Saos-2 cells was determined in a plate reader by recording absorbance at 570 nm. In Western blot analysis, bicinconinic acid (BCA) method was used to determine protein concentration. Flow cytometry was employed to measure DNA content.
Results: Cucurbitacin B treatment inhibits the expression of SENP5 in U2OS and Saos-2 osteosarcoma cells in a dose- and time-dependent manner. Significant inhibition (p = 0.005) of SENP5 expression was observed at 50 mg/ml from day 10, reaching a maximum on day 20. It also induced a significant decrease (p = 0.005) in mRNA and protein levels of SENP5. The decrease in mRNA and protein levels of SENP5 led to decrease in proliferation of U2OS and Saos-2 cells. The 48 h cell cultures containing 50 mg of cucurbitacin B caused induction of apoptosis in 54.72 ± 5.42 % of the total cell population in U2OS cells. Similarly, in Saos-2 cells, exposure to 50 mg/mL cucurbitacin B increased apoptotic rate from 9.86 ± 8.89 % for 10 mg/mL to 48.54 ± 14.5 % with 50 mg/mL of cucurbitacin B.
Conclusion: Cucurbitacin B is a potential therapeutic strategy for the treatment of aggressive malignancy in osteosarcoma.

Cucurbitacin B; Osteosarcoma; SUMO-specific proteases; Cell proliferation; Apoptosis; Malignancy

© Copyright 2015 - Tropical Journal of Pharmaceutical Research
Alternative site location:

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2023, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil